3-Propoxypyridazine

Catalog No.: 
ACGAOO273
CAS No.: 
748141-89-1
Molecular Formula: 
C7H10N2O
Molecular Weight: 
138.17
3-Propoxypyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$236.00InquiryInquiry
100mg95%$340.00InquiryInquiry
250mg95%$478.00InquiryInquiry
1g95%$949.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Propoxypyridazine
IUPAC Name3-propoxypyridazine
MDL No.MFCD16619335
Molecular FormulaC7H10N2O
Molecular Weight138.17
SMILESCCCOC1=NN=CC=C1
InChI KeySOKDEAVXEOZNKS-UHFFFAOYSA-N
Synonym3-Propoxypyridazine;Pyridazine,3-propoxy-;3-Propoxypyridazine ISO 9001:2015 REACH
CAS No.748141-89-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGAOO273 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNMJX619 route compound structure diagram
    ACNMJX6191120-95-2In Stock
  4. Then
  5. ACGAOO273 route product structure diagram
    ACGAOO273748141-89-1
Inquiry

2. ACGAOO273 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEFTD879 route compound structure diagram
    ACEFTD87988491-61-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGAOO273 route product structure diagram
    ACGAOO273748141-89-1
Inquiry

3. ACGAOO273 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAXQL849 route compound structure diagram
    ACAXQL849504-30-3In Stock
  4. Then
  5. ACGAOO273 route product structure diagram
    ACGAOO273748141-89-1
Inquiry

Comments (0)